Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer von Sahin, Ugur, Derhovanessian, Evelyna, Miller, Matthias, Kloke, Björn-Philipp, Simon, Petra, Löwer, Martin, Bukur, Valesca, Tadmor, Arbel D., Luxemburger, Ulrich, Schrörs, Barbara, Omokoko, Tana, Vormehr, Mathias, Albrecht, Christian, Paruzynski, Anna, Kuhn, Andreas N., Buck, Janina, Heesch, Sandra, Schreeb, Katharina H., Müller, Felicitas, Ortseifer, Inga, Vogler, Isabel, Godehardt, Eva, Attig, Sebastian, Rae, Richard, Breitkreuz, Andrea, Tolliver, Claudia, Suchan, Martin, Martic, Goran, Hohberger, Alexander, Sorn, Patrick, Diekmann, Jan, Ciesla, Janko, Waksmann, Olga, Brück, Alexandra-Kemmer, Witt, Meike, Zillgen, Martina, Rothermel, Andree, Kasemann, Barbara, Langer, David, Bolte, Stefanie, Diken, Mustafa, Kreiter, Sebastian, Nemecek, Romina, Gebhardt, Christoffer, Grabbe, Stephan, Höller, Christoph, Utikal, Jochen, Huber, Christoph, Loquai, Carmen, Türeci, Özlem

Volltext

Determinants of FIV and HIV Vif sensitivity of feline APOBEC3 restriction factors von Zhang, Zeli, Gu, Qinyong, Jaguva Vasudevan, Ananda Ayyappan, Hain, Anika, Kloke, Björn-Philipp, Hasheminasab, Sascha, Mulnaes, Daniel, Sato, Kei, Cichutek, Klaus, Häussinger, Dieter, Bravo, Ignacio G, Smits, Sander H J, Gohlke, Holger, Münk, Carsten

Volltext

The right patient for the right therapy: 13th Annual Meeting of the Association for Cancer Immunotherapy (CIMT), Mainz, Germany, May 11–13, 2015 von Miller, Matthias, Jahndel, Veronika, Kutscher, Sarah, Mahr, Andrea, Rae, Richard, Kloke, Björn-Philipp

Volltext

Multiple Restrictions of Human Immunodeficiency Virus Type 1 in Feline Cells von MÜNK, Carsten, ZIELONKA, Jörg, CONSTABEL, Hannelore, KLOKE, Björn-Philipp, RENGSTL, Benjamin, BATTENBERG, Marion, BONCI, Francesca, PISTELLO, Mauro, LÖCHELT, Martin, CICHUTEK, Klaus

Volltext

Species-specific Inhibition of APOBEC3C by the Prototype Foamy Virus Protein Bet von Perković, Mario, Schmidt, Stanislaw, Marino, Daniela, Russell, Rebecca A., Stauch, Benjamin, Hofmann, Henning, Kopietz, Ferdinand, Kloke, Björn-Philipp, Zielonka, Jörg, Ströver, Heike, Hermle, Johannes, Lindemann, Dirk, Pathak, Vinay K., Schneider, Gisbert, Löchelt, Martin, Cichutek, Klaus, Münk, Carsten

Volltext

Cancer immunotherapy achieves breakthrough status: 12th annual meeting of the association for cancer immunotherapy (CIMT), Mainz, Germany, May 6–8, 2014 von Kloke, Björn-Philipp, Mahr, Andrea, Jabulowsky, Robert A., Kutscher, Sarah, Rae, Richard, Britten, Cedrik M.

Volltext

Tropism, intracerebral distribution, and transduction efficiency of HIV- and SIV-based lentiviral vectors after injection into the mouse brain: a qualitative and quantitative in vi... von Hlavatý, Juraj, Tonar, Zbyněk, Renner, Matthias, Panitz, Sylvia, Petznek, Helga, Schweizer, Matthias, Schüle, Silke, Kloke, Björn-Philipp, Moldzio, Rudolf, Witter, Kirsti

Volltext

Toward the next waves of cancer immunotherapy: 11th Annual Meeting of the Association for Cancer Immunotherapy (CIMT), Mainz, Germany, May 14–16, 2013 von Kloke, Björn-Philipp, Rae, Richard, Mahr, Andrea, Burkhardt, Ute E., Kvistborg, Pia, Britten, Cedrik M.

Volltext

Restriction of HIV-1 replication in monocytes is abolished by Vpx of SIVsmmPBj von Schüle, Silke, Kloke, Björn-Philipp, Kaiser, Julia K, Heidmeier, Sabine, Panitz, Sylvia, Wolfrum, Nina, Cichutek, Klaus, Schweizer, Matthias

Volltext

IL-15 augments antitumoral activity of an ErbB2/HER2 cancer vaccine targeted to professional antigen-presenting cells von Burkhardt, Ute E., Sloots, Arjen, Jakobi, Vera, Wei, Wei-Zen, Cavallo, Federica, Kloke, Björn-Philipp, Wels, Winfried S.

Volltext

Toward next-generation cancer immunotherapy: 10th Annual Meeting of the Association for Cancer Immunotherapy (CIMT), Mainz, Germany, May 23–25, 2012 von Kloke, Björn-Philipp, Kutscher, Sarah, Rae, Richard, Kvistborg, Pia, Britten, Cedrik M., Hadrup, Sine Reker

Volltext

Functional HIV-2- and SIVsmmPBj- derived lentiviral vectors generated by a novel polymerase chain reaction-based approach von Kloke, Björn-Philipp, Schüle, Silke, Mühlebach, Michael D., Wolfrum, Nina, Cichutek, Klaus, Schweizer, Matthias

Volltext

Comparative Analysis of Transduced Primary Human Dendritic Cells Generated by the Use of Three Different Lentiviral Vector Systems von Grabski, Elena, Waibler, Zoe, Schüle, Silke, Kloke, Björn-Philipp, Sender, Linda Y, Panitz, Sylvia, Cichutek, Klaus, Schweizer, Matthias, Kalinke, Ulrich

Volltext

Impact of viral accessory proteins of SIVsmmPBj on early steps of infection of quiescent cells von Wolfrum, Nina, Mühlebach, Michael D, Schüle, Silke, Kaiser, Julia K, Kloke, Björn-Philipp, Cichutek, Klaus, Schweizer, Matthias

Volltext

Mechanisms of efficacy in cancer immunotherapy: 14th Annual Meeting of the Association for Cancer Immunotherapy (CIMT), Mainz, Germany, May 10–12, 2016 von Theelen, Judith, Braun, Jennifer, Hörzer, Helen, Kloke, Bjoern-Philipp, Ott, Martina, Pizzitola, Irene, Schirmer, Uwe, Miller, Matthias

Volltext

Abstract CT020: MERIT: introducing individualized cancer vaccines for the treatment of TNBC - a phase I trial von Heesch, Sandra, Bukur, Valesca, Buck, Janina, Diekmann, Jan, Diken, Mustafa, Ewen, Kerstin, Haas, Heinrich, Kemmer-Brueck, Alexandra, Kloke, Björn-Philipp, Kreiter, Sebastian, Kuhn, Andreas N., Kuehlcke, Klaus, Loewer, Martin, Paruzynski, Anna, Schultheiß, Kathrin, Schwarck, Doreen, Schmidt, Marcus, André, Fabrice, De Greve, Jacques, Kuendig, Thomas, Lindman, Henrik, Pascolo, Steve, Sjöblom, Tobias, Thielemans, Kris, Zitvogel, Laurence, Türeci, Özlem, Sahin, Ugur

Volltext

METHOD AND DEVICE FOR DETERMINING THE WEAR ON A DEVICE FOR PROCESSING PLASTICS von FAULHABER, Werner, KLOKE, Philipp

Volltext bestellen

SynErgie - Synchronisierte und energieadaptive Produktionstechnik zur flexiblen Ausrichtung von Industrieprozessen auf eine fluktuierende Energieversorgung : Schlussbericht Teilvor... von Kloke, Philipp

Volltext bestellen

METHOD AND DEVICE FOR DETERMINING WEAR ON A PLASTIC PROCESSING DEVICE von FAULHABER WERNER, KLOKE PHILIPP

Volltext bestellen

Abstract CT022: IVAC® MUTANOME - A first-in-human phase I clinical trial targeting individual mutant neoantigens for the treatment of melanoma von Miller, Matthias, Loquai, Carmen, Kloke, Björn-Philipp, Attig, Sebastian, Bidmon, Nicole, Bolte, Stefanie, Bukur, Valesca, Derhovanessian, Evelyna, Diekmann, Jan, Filbry, Angela, Heesch, Sandra, Hoeller, Christoph, Kuehlcke, Klaus, Langer, David, Loewer, Martin, Mueller, Felicitas, Ortseifer, Inga, Otte, Burkhard, Paruzynski, Anna, Rae, Richard, Schroers, Barbara, Seck, Christine, Spiess, Kristina, Tadmor, Arbel D., Vogler, Isabel, Vormehr, Mathias, Kemmer-Brueck, Alexandra, Kuhn, Andreas N., Luxemburger, Ulrich, Kreiter, Sebastian, Utikal, Jochen, Grabbe, Stephan, Tuereci, Oezlem, Sahin, Ugur

Volltext